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SUMMARY
Approximately 50% of prostate cancers are associ-
ated with gene fusions of the androgen-regulated
gene TMPRSS2 to the oncogenic erythroblast trans-
formation-specific (ETS) transcription factor ERG.
The three-dimensional proximity of TMPRSS2 and
ERG genes, in combination with DNA breaks, facili-
tates the formation of TMPRSS2-ERG gene fusions.
However, the origins of DNA breaks that underlie
gene fusion formation in prostate cancers are far
from clear. We demonstrate a role for inflamma-
tion-induced oxidative stress in the formation of
DNA breaks leading to recurrent TMPRSS2-ERG
gene fusions. The transcriptional status and epige-
netic features of the target genes influence this
effect. Importantly, inflammation-induced de novo
genomic rearrangements are blocked by homolo-
gous recombination (HR) and promoted by non-
homologous end-joining (NHEJ) pathways. In
conjunction with the association of proliferative
inflammatory atrophy (PIA) with human prostate
cancer, our results support a working model in
which recurrent genomic rearrangements induced
by inflammatory stimuli lead to the development of
prostate cancer.
INTRODUCTION
There is considerable evidence for the role of inflammation in the
development of several forms of human cancer (Balkwill andMan-
tovani, 2001; Coussens andWerb, 2002; Grivennikov et al., 2010);
however, the mechanistic details are not clear. Prostate cancer
in particular has been associated with proliferative inflammatory
atrophy (PIA), aputativeprecursor lesion indicativeofan inflamma-
tory etiology (De Marzo et al., 1999, 2007). In terms of recurrent
driver mutations, approximately 50% of prostate cancers are
associated with gene fusions of the androgen-regulated gene
TMPRSS2 to the oncogenic erythroblast transformation-specific
(ETS) transcription factor ERG (Tomlins et al., 2005). Androgen
signaling induces spatial proximity between the TMPRSS2 and
the ERG gene loci, which in combination with gamma irradiation-
induced DNA breaks, facilitates the formation of gene fusions
(Lin et al., 2009; Mani et al., 2009). That said, the in vivo mecha-
nisms contributing to DNA breaks that underlie the formation of
TMPRSS2-ERG are far from clear. Here, we explore the hypothe-
sis that inflammationplaysakey role in thegenesisofprostatecan-
cer by promoting the formation of recurrent gene rearrangements.
RESULTS
Inflammation Induces TMPRSS2-ERG Gene Fusion
Formation
The cytokine, tumor necrosis factor alpha (TNF-a), plays a cen-
tral role in orchestrating the inflammatory response (Baud and
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Karin, 2001). To initially recapitulate the effects of inflammation
in vitro, we stimulated the TMPRSS2-ERG gene fusion-negative
LNCaP prostate cancer cells with TNF-a for 48 hr. To our sur-
prise, we observed robust formation of the TMPRSS2-ERG
gene fusion transcript by TNF-a stimulation, as assessed by
TaqMan-based qRT-PCR and gel-based RT-PCR (Figures 1A
and 1B). Gene fusion formation induced by TNF-a was equal
to, or more efficient than, exposure to 5 and 50 Gy irradiation
(Figure S1A), which we and others have reported on (Haffner
et al., 2010; Lin et al., 2009; Mani et al., 2009). This was particu-
larly exciting in that the prostate gland is more likely to be
exposed to pro-inflammatory stimuli than to large doses of
gamma radiation, making inflammation a more physiologic
inducer of gene fusions. The short timescale of these experi-
ments and the observation that stimulation with TNF-a does
not increase the levels of TMPRSS2-ERG or total ERG tran-
scripts in VCaP cells, which endogenously harbor the
TMPRSS2-ERG gene fusion (Tomlins et al., 2005), indicate that
the observed effects are not due to selective growth or survival
conferred by the treatment or due to an increase in transcript
levels from a fixed population of cells with rearrangements
already present (Figure S1B). We therefore report the genesis
of gene fusions in the absence of clonal selection. On the basis
of standard curve analysis of serially diluted VCaP cells, we es-
timate the induced TMPRSS2-ERG rearrangement frequency
in LNCaP cells to be about one event in 10,000 cells (Figure S1C).
Sequence analysis of the TNF-a-induced fusion transcripts in
LNCaP cells revealed joining of the first exon of TMPRSS2 with
exon 4 of ERG, which is the most common TMPRSS2-ERG iso-
form in prostate cancers and is also endogenously present in
VCaP prostate cancer cells (Figure 1C) (Tomlins et al., 2005).
We next examined the role of androgen signaling in TNF-
a-mediated TMPRSS2-ERG gene fusion formation. Depletion
of androgens from the media or androgen receptor (AR) knock-
down by small interfering RNA (siRNA) blocks TMPRSS2-
ERG gene fusion formation upon TNF-a stimulation (Figures
1D and 1E). In addition to LNCaP cells, we observe TNF-
a-induced TMPRSS2-ERG gene fusion formation in LAPC-4
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Figure 1. Inflammation Induces TMPRSS2-
ERG Gene Fusion Formation
(A) Demonstration of TMPRSS2-ERG gene fusion
transcript formation in LNCaP cells upon stimula-
tion with TNF-a (100 ng/mL) for 48 hr by gel-based
RT-PCR analysis. Each treatment is represented by
24 samples.
(B) TaqMan qRT-PCR analysis of the TMPRSS2-
ERG fusion transcripts in LNCaP cells treated with
PBS (n = 23) is compared to TNF-a treatment
(100 ng/mL for 48 hr; n = 23; p < 0.01 by two-tailed
Mann-Whitney U-test). Each data point represents
the mean of two technical replicates from an inde-
pendent treatment.
(C) Sequence analysis of TMPRSS2-ERG tran-
scripts in TMPRSS2-ERG-positive LNCaP cells
obtained by TNF-a stimulation. Gene structures for
TMPRSS2 and ERG, respectively, are shown using
GenBank: NM_005656 and NM_004449.
(D) Androgen receptor (AR) knockdown blocks
TNF-a-mediated TMPRSS2-ERG gene fusion for-
mation in LNCaP cells. The top panel represents
qRT-PCR analysis of TMPRSS2-ERG fusion tran-
scripts (*p < 0.01 by two-tailed Student’s t test;
error bars, SEM of two technical replicates). The
bottom panel represents the immunoblot analysis
to determine AR knockdown.
(E) qRT-PCRanalysis indicates a role for androgens
in the formation of TMPRSS2-ERG gene fusion
transcripts in LNCaP cells (*p < 0.01 by two-tailed
Student’s t test; error bars, SEM of three technical
replicates).
(F) Induction of TMPRSS2-ERG gene fusion tran-
scripts in the AR-positive cell line, LAPC-4, upon
stimulation with TNF-a (100 ng/mL for 48 hr), but
not in the AR-negative cell line, DU145. TaqMan
qRT-PCR analysis of the TMPRSS2-ERG fusion
transcript in LAPC-4 or DU145 cells treated with
PBS (n = 5) is compared to TNF-a treatment (n = 5;
*p < 0.01 by two-tailedMann-Whitney U-test). Each
data point represents the mean of two technical
replicates from an independent treatment. See also
Figure S1.
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cells that are androgen sensitive. However, the androgen-insen-
sitive DU145 cells are resistant to TNF-a-induced gene fusion
formation (Figures 1F and S1D). Stimulation of LNCaP cells
with TNF-a does not result in detectable levels of TMPRSS2-
ETV1 gene fusion or BCR-ABL1 gene fusion, products of
inter-chromosomal rearrangement observed in <5% of prostate
cancers (Tomlins et al., 2007) or in most chronic myelogenous
leukemia (CML) cases (Rowley, 1973) respectively (Figure S1E).
Collectively, these results indicate that (1) genomic rear-
rangements are non-random, cell-type-specific events dictated
by lineage-restricted cell signaling pathways (e.g., androgen
signaling in prostate cancer), and (2) intra-chromosomal rear-
rangements (e.g., TMPRSS2-ERG) are more prevalent than
inter-chromosomal rearrangements.
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Figure 2. Inflammation Induces De Novo
Genomic Rearrangements
(A) RAD51 foci formation upon treatment of LNCaP
cells with TNF-a (100 ng/mL). Cells were processed
48 hr post-treatment. Scale bar indicates 10 mm
(left). The staining intensity of Rad51 foci was
analyzed using the CellProfiler software for 165
nuclei per treatment (*p < 0.01 by two-tailed Mann-
Whitney U-test) (right).
(B and C) FISH-based detection of DNA breaks
at the TMPRSS2 locus (B) and the ERG locus (C).
Untreated LNCaP cells are compared to those with
TNF-a stimulation (100 ng/mL), 5 Gy gamma irra-
diation, and 50 Gy gamma irradiation. Cells were
processed 48 hr post-treatment. Split signals rep-
resenting DNA breaks are highlighted by arrows.
The FISH images are accompanied by histograms
representing the percentage of nuclei with split
signals. For TMPRSS2 and ERG loci, 100 nuclei
were analyzed per treatment (*p < 0.05 by two-
tailed Student’s t test; error bars, SEM of two
technical replicates).
(D) Probe-based custom genomic DNA capture,
sequencing, and analysis of LNCaP cells with the
indicated treatments. Stimulation with TNF-a in-
duces the formation of de novo chromosomal
translocations (top panel). Homologous recombi-
nation (HR) deficiency (combined ATM, BRCA1,
and RAD51 knockdown) per se is relatively ineffi-
cient in inducing chromosomal translocations in
the absence of external stress. A combination of
TNF-a stimulation and HR deficiency synergisti-
cally induces the formation of de novo chromo-
somal translocations (bottom panel). Genomic
rearrangement breakpoints were called from the
capture sequencing data and are presented here,
grouped by treatment and plotted with Circos. See
also Figures S2–S5.
Inflammation Induces DNA Double-
Strand Breaks and De Novo
Genomic Rearrangements
To demonstrate that DNA damage
occurs upon exposure of LNCaP cells to
TNF-a, we monitored phosphorylated his-
tone H2A.X (Ser139), which was elevated
within 12 hr of exposure (Figure S2A) and
was recruited to known translocation sites at TMPRSS2 and
ERG loci (Figure S2B). Stimulation of LNCaPwith TNF-a resulted
in RAD51 foci formation, indicating initiation of DNA repair func-
tion (Figure 2A). Furthermore, by employing a split-signal-based
dual-color fluorescence in situ hybridization (FISH) assay, we
observed breaks in the TMPRSS2 and ERG loci upon stimulation
of LNCaP cells with TNF-a (Figures 2B and 2C). Gamma radia-
tion (5 and 50 Gy), as previously shown (Lin et al., 2009; Mani
et al., 2009), induced breaks in these loci and was included as
a positive control. We observed that TMPRSS2 is more prone
to DNA breaks in comparison to ERG. Because TMPRSS2 is
transcriptionally active before the formation of gene fusions,
and ERG is not, we speculate that the frequency of DNA breaks
at a locus is correlated with its transcriptional activity.
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We developed a custom capture sequencing pipeline to study
inflammation-induced de novo genomic rearrangements at the
single-molecule level in the absence of clonal selection. We
designed probes to capture TMPRSS2, ERG, and a few control
loci (e.g., MIPOL1 and DGKB), followed by deep sequencing
(>2,0003 depth) and analysis. To benchmark our analysis pipe-
line, we characterized the genomic breakpoints associated with
MIPOL1-DGKB gene fusion, a clonal rearrangement in LNCaP
cells, characterized by two cryptic insertions of a minimal region
around ETV1 (chromosome 7) into the MIPOL1 gene (chromo-
some 14) (Maher et al., 2009; Tomlins et al., 2007). We rediscov-
ered the known genomic breakpoint between MIPOL1 and
DGKB and also identified a novel second genomic breakpoint
between the two genes (Figure S3A). Both breakpoints are asso-
ciated with junction microhomologies of four and two nucleo-
tides, respectively (Figure S3B).
Next, we de-convoluted the genomic rearrangements associ-
ated with TMPRSS2-ERG gene fusion in VCaP cells. We redis-
covered the four reported breakpoints (Teles Alves et al., 2013;
Weier et al., 2013), including an inter-chromosomal rearrange-
ment (Figures S3C and S3D). Two of the four breakpoints ex-
hibited blunt junctions; the remaining two breakpoints displayed,
respectively, a single nucleotide junction microhomology and
an eight-nucleotide ‘‘non-templated’’ insertion that could not
be aligned to either of the contributing loci (Figure S3E). Sanger
sequencing analysis confirmed a complex genomic rear-
rangement involving the sense strand of TMPRSS2 intron 1,
the antisense strand of TMPRSS2 intron 5, and the sense strand
of ERG intron 3 as the genomic event contributing to the
TMPRSS2-ERG gene fusion (Figure S4).
We applied this analysis pipeline to study LNCaP cells treated
with PBS or TNF-a. We observed robust formation of de novo
genomic rearrangements upon TNF-a stimulation (Figure 2D).
Because the short experimental time frame precludes clonal
selection, all discovered rearrangements represent single-mole-
cule events. Our stringent algorithm selected only those rear-
rangements that were supported by junction spanning reads,
thereby facilitating detailed analysis of junction characteristics
and repair mechanisms.
Because homologous recombination (HR) has been sug-
gested to maintain genome integrity by blocking genomic rear-
rangements (Moynahan and Jasin, 2010), we tested the effect
of a defective HR by simultaneous knockdown of ATM,
BRCA1, and RAD51, key players in the HR pathway (Figure S5).
Due to the functional redundancy among the major HR players,
we hypothesized that silencing multiple HR components will
significantly inhibit the HR pathway. We observed that a defec-
tive HR, in the absence of an external stress, is relatively ineffi-
cient in the formation of genomic rearrangements. A combina-
tion of TNF-a stimulation and HR deficiency further increased
the formation of de novo genomic rearrangements (Figure 2D).
The generally low frequency of the specific genomic rearrange-
ment between TMPRSS2 and ERG genes, due to the absence
of clonal selection, precluded us from identifying DNA rearrange-
ment junctions between these two genes. Hence, we focused
on identifying the general principles underlying TNF-a-induced
DNA rearrangements involving TMPRSS2 or ERG rather than
DNA rearrangements between TMPRSS2 and ERG genes.
DNA Sequence and Epigenetic Features of TNF-
a-Induced De Novo Genomic Rearrangements
About 75% (19/25) of the induced de novo genomic rearrange-
ment breakpoints exhibit junction microhomology ranging from
one to six nucleotides (Figures 3A–3F and S6A). The observed
breakpoints exhibited an average microhomology length of
1.84 bp, significantly longer than the average length obtained
from 10,000 simulated sets of randomly generated breakpoints
(p < 0.0001) (Figure 3G). Two of the six blunt junctions exhibit mi-
crohomology on the reverse strand, a previously undescribed
phenomenon. We speculate that reverse microhomology may
facilitate genomic rearrangements by a mechanism involving
transient base pairing (Figure S6B). The de novo DNA rearrange-
ments induced by inflammation have characteristics observed in
cancer-associated translocations, because a study reported 1 to
4 bp microhomology in most translocation junctions in prostate
cancer specimens (Weier et al., 2013). Altogether, these charac-
teristics of the induced breakpoint junctions implicate microho-
mology-mediated non-homologous end-joining (NHEJ) as the
pathway associated with de novo genomic rearrangements.
The recurrently fused intron 3 of ERG is 130 kb long and is one
of the largest introns in the human genome (Figure 3H). We
hypothesized that the DNA sequence and epigenetic features
afforded by the large intron size could dictate the formation
of TNF-a-induced breaks in a transcription-independent
manner. We queried the induced de novo breakpoints against
DNA sequence features like non-B DNA structures (inverted
repeats, mirror repeats, direct repeats, G-quadruplex-forming
repeats, Z-DNA repeats, A-phased repeats, and short tandem
repeats). None of these features demonstrated significant
enrichment near the observed breakpoints. Upon ruling out
DNA sequence elements, we analyzed epigenetic features by
querying datasets generated by the Encyclopedia of DNA
Elements (ENCODE) project (Consortium et al., 2012; Thurman
et al., 2012). A significant fraction of the genomic breakpoints
identified in ERG lay within DNase I hypersensitivity sites
(DHSs) (43.75%, p < 0.0001); the genomic breakpoints in
TMPRSS2 were not significantly enriched in DHSs (Figure 3I).
This result suggests that DNase I hypersensitivity, and by exten-
sion open chromatin, may contribute to the formation of some
genomic breaks in ERG. We conclude that breaks in TMPRSS2
are dictated by its transcriptional status and breaks in ERG by
epigenetic features like DHSs.
Oxidative Stress as the Mediator of
Inflammation-Induced Gene Fusion Formation
TNF-a stimulation has been reported to increase reactive oxygen
species (ROS) production via multiple mechanisms (Blaser et al.,
2016; Chandel et al., 2001; Kim et al., 2007, 2010; Yazdanpanah
et al., 2009). We hypothesized that oxidative stress-mediated
DNA damage may be the underlying mechanism for the gen-
eration of DNA double-strand breaks required for gene fusion
formation. Stimulation of LNCaP cells with TNF-a resulted in a
dose-dependent increase in ROS production (Figure 4A).
Consistent with earlier studies (Kim et al., 2010), we observed
that treatment with cycloheximide (CHX), an inhibitor of protein
biosynthesis, enhanced TNF-a-induced ROS production (Fig-
ure 4A). This is presumably due to CHX-induced blockade of
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nuclear factor kB (NF-kB)-mediated antioxidant production.
TNF-a-induced ROSproduction can be reversed upon treatment
with the ROS scavenger N-acetylcysteine (NAC) (Figure 4A).
TNF-a-induced ROS production and DNA damage were also
observed in the androgen-sensitive LAPC-4 cells, androgen-
insensitive DU145 cells, and benign immortalized non-trans-
formed RWPE-1 cells (Figures 4B and 4C). Thus, we conclude
that androgen signaling is not required for TNF-a-mediated
formation of DNA breaks. Rather, AR redirects ROS-mediated
DNA damage to the TMPRSS2 locus by enhancing transcription,
opening up the DNA, and thereby making it susceptible to DNA
double-strand breaks. TNF-a-induced DNA breaks in the ERG
locus are likely to be AR independent. This set the stage for
the next set of experiments to test the role of oxidative stress
in gene fusion formation.
The Role of ROS in ETS Gene Fusion Formation
Althoughsingle-agent treatment of LNCaPcellswith either TNF-a
or CHX induced DNA damage, a combination of TNF-a and CHX
markedly enhanced the extent of the DNA damage, as visualized
0
20
00
40
00
60
00
80
00
10
00
0
Fraction of Breakpoints with Microhomology ≥ 6bp
Fr
eq
ue
nc
y 
of
 S
im
ul
at
ed
 D
at
as
et
s
0% 20% 40% 60% 80% 100%
0
20
00
40
00
60
00
80
00
10
00
0
Fraction of Breakpoints with Microhomology ≥ 5bp
Fr
eq
ue
nc
y 
of
 S
im
ul
at
ed
 D
at
as
et
s
0% 20% 40% 60% 80% 100%
0
10
00
20
00
30
00
40
00
50
00
60
00
70
00
Fraction of Breakpoints with Microhomology ≥ 4bp
Fr
eq
ue
nc
y 
of
 S
im
ul
at
ed
 D
at
as
et
s
0% 20% 40% 60% 80% 100%
0
10
00
20
00
30
00
40
00
Fraction of Breakpoints with Microhomology ≥ 3bp
Fr
eq
ue
nc
y 
of
 S
im
ul
at
ed
 D
at
as
et
s
0% 20% 40% 60% 80% 100%
0
50
0
10
00
15
00
20
00
25
00
Fraction of Breakpoints with Microhomology ≥ 2bp
Fr
eq
ue
nc
y 
of
 S
im
ul
at
ed
 D
at
as
et
s
0% 20% 40% 60% 80% 100%
0
50
0
10
00
15
00
20
00
Fraction of Breakpoints with Microhomology ≥ 1bp
Fr
eq
ue
nc
y 
of
 S
im
ul
at
ed
 D
at
as
et
s
0% 20% 40% 60% 80% 100%
3000.0=p1000.0<p2000.0=p
2840.0=p3900.0=p2100.0=p
Microhomology (≥3bp)CMicrohomology (≥2bp)BMicrohomology (≥1bp)A
Microhomology (≥6bp)FMicrohomology (≥5bp)EMicrohomology (≥4bp)D
0
10
00
20
00
30
00
40
00
50
00
60
00
Fraction of Breakpoints within 
DHS peaks (+/− 0kb)
0% 50% 100%
p = 1
I
0
10
00
20
00
30
00
40
00
0% 25% 50% 75% 100%
Fraction of Breakpoints within 
DHS peaks (+/− 0kb)
G
Microhomology Length Distribution
of Simulated Breakpoints
Microhomology Length (bp)
Fr
eq
ue
nc
y 
of
 S
im
ul
at
ed
 D
at
as
et
s
Fr
eq
ue
nc
y 
of
 S
im
ul
at
ed
 D
at
as
et
s
0.0 0.5 1.0 1.5 2.01.84
0
20
0
40
0
60
0
80
0
10
00
0% 20% 40% 60% 80% 100%
In
tro
n 
Le
ng
th
 (b
p)
ERG Intron 3 (99.49%)
TMPRSS2 Intron 1 (87.54%)
H
106
105
104
103
102
101
Intron (Percentile)
All introns, by Length 
(Protein Coding Ensembl Transcripts) 
Fr
eq
ue
nc
y 
of
 S
im
ul
at
ed
 D
at
as
et
sp < 10-4
p < 10-4
Frequency distribution of DHS concordance
with Simulated Random Breakpoints in ERG 
Frequency distribution of DHS concordance
with Simulated Random Breakpoints in TMPRSS2
Figure 3. DNA Sequence and Epigenetic
Features of TNF-a-Induced De Novo
Genomic Rearrangements
(A–F) TNF-a-induced de novo chromosomal
translocations are associated with junction micro-
homologies. The 25 observed genomic break-
points were compared with distributions of
randomly simulated breakpoints (10,000 sets of 25
breakpoints) for six measures of junction micro-
homology. A significantly greater fraction of the
observed breakpoints exhibited junction micro-
homology than expected by chance, for any length
up to six bases. Of the observed breaks, 76%
have 1 bp or more of junction microhomology
(p = 0.0002) (A), 52%have 2 bp ormore (p = 0.0001)
(B), 28% have 3 bp or more (p = 0.0003) (C), 16%
have 4 bp or more (p = 0.0012) (D), 8% have 5 bp or
more (p = 0.0093) (E), and 4% have 6 bp or more
(p = 0.0482) (F).
(G) The 25 observed genomic breakpoints were
compared with distributions of randomly simulated
breakpoints (10,000 sets of 25 breakpoints) for
junction microhomology length. The observed
breakpoints exhibited an average microhomology
length of 1.84 bp, significantly longer than ex-
pected by chance (p < 0.0001).
(H) ERG’s recurrently fused intron is among the
largest in the genome. Protein-coding genes in
chromosomes 1–22, X, and Y were selected from
the Ensembl gene reference, and the longest
transcript was taken as representative of each
gene. Intron sizes were interpolated from transcript
exon boundaries and then sorted and plotted as
shown. ERG’s recurrently fused intron is 130,040
bases long and is thus larger than 99.49% of
annotated introns. TMPRSS2’s recurrently fused
intron is 9,891 bases long and is thus larger than
87.54% of annotated introns.
(I) Association between ERG genomic breakpoints
and DNase I hypersensitivity sites (DHSs). DHS
peak data were acquired from the ENCODE data
portal and filtered for sites identified in greater than
10% of the 125 cell lines profiled. The observed
induced genomic breakpoints within ERG and
TMPRSS2 were then compared with distributions
of randomly simulated breakpoints (10,000 sets of
16 and 10,000 sets of 4). A significantly greater
fraction of the genomic breakpoints identified in
ERG lay within DHSs than expected from the
random distribution (43.75%; p < 0.0001) (left).
The genomic breakpoints in TMPRSS2 were not
significantly enriched in DHSs (right).
See also Figure S6.
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by phosphorylated histone H2A.X (Ser139) western blotting (Fig-
ure 5A). Consistent with this observation, the combination of
TNF-a and CHX significantly increased TMPRSS2-ERG gene
fusion formation in comparison to single-agent treatments (Fig-
ure 5B). TNF-a-induced TMPRSS2-ERG formation was blocked
by treatment with NAC (Figure 5B). Thus, ROS is the mediator
of TNF-a-induced TMPRSS2-ERG gene fusion formation. To
recapitulate the effect of TNF-a-induced ROS formation, we
treated LNCaP cells with H2O2. Treatment with H2O2 resulted in
a dose-dependent increase in DNA breaks and TMPRSS2-ERG
gene fusion formation (Figures 5C and 5D). The induction of
TMPRSS2-ERG gene fusion with H2O2 was orders of magnitude
higher than stimulation with TNF-a alone. H2O2 treatment also
induced the formation of the inter-chromosomal TMPRSS2-
ETV1 rearrangement, although the frequency was very low (Fig-
ures 5E and 5F). However, we did not observe H2O2-induced for-
mation BCR-ABL1 rearrangement in LNCaP cells, although BCR
andABL1 genes are expressed in these cells (Figure S7A). These
results provide further support to the conclusion that gene fu-
sions originate in a non-random, cell-type-dependent manner.
Air-Pouch Model of Inflammation to Study Gene Fusions
Next, we explored whether gene fusions can be induced by
inflammation in an in vivo setting. To do this, we took advantage
of a well-studiedmurine model of in vivo inflammation, which oc-
curs in an artificial air pouch (Edwards et al., 1981). The air pouch
Figure 4. TNF-a Stimulation and Intracellular ROS Level
(A) Analysis of ROS formation in LNCaP cells by flow cytometry. The blue and red plots represent treatment and matched controls, respectively. The X axis and
Y axis represent ROS level and cell count, respectively, for all plots. TNF-a doses are as indicated. 10 mM N-acetylcysteine (NAC) and 10 mg/mL cyclo-
heximide (CHX) were used in the study. All plots represent 24 hr treatment, with the exception of H2O2, a positive control used in the study (3.5 hr treatment)
(bottom left).
(B) Analysis of TNF-a-induced (24 hr treatment) ROS formation in LAPC-4, DU145, and RWPE-1 cells.
(C) Immunoblot analysis of lysates from LAPC-4, DU145, and RWPE-1 cells stimulated with TNF-a (100 ng/mL) for 24 hr are shown with antibodies against
phosphorylated histone H2A.X (Ser139) (top), and total histone H2A.X (bottom).
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Figure5. OxidativeStress InducesTMPRSS2-
ERG and TMPRSS2-ETV1 Gene Fusion
Formation
(A) Immunoblot analysis of lysates from LNCaP
cells stimulated with TNF-a (100 ng/mL), CHX
(10 mg/mL), or a combination of TNF-a and CHX for
24 hr are shown with antibodies against phos-
phorylated histone H2A.X (Ser139) (top) and total
histone H2A.X (bottom).
(B) qRT-PCR analysis of TMPRSS2-ERG fusion
transcripts from LNCaP cells with the indicated
treatments for 48 hr (*p < 0.05 by two-tailed Stu-
dent’s t test; error bars, SEM of two technical
replicates).
(C) Immunoblot analysis of lysates from LNCaP
cells stimulated with the indicated doses of H2O2
for 24 hr are shown with antibodies against phos-
phorylated histone H2A.X (Ser139) (top) and total
histone H2A.X (bottom).
(D) qRT-PCR analysis of TMPRSS2-ERG fusion
transcripts from LNCaP cells with the indicated
dose of H2O2 treatment for 48 hr (*p < 0.01 by two-
tailed Student’s t test; error bars, SEM of two
technical replicates).
(E) Demonstration of TMPRSS2-ETV1 gene fusion
transcript formation in LNCaP cells upon stimula-
tion with H2O2 (1 mM for 48 hr) by gel-based RT-
PCR analysis. The box highlights a band repre-
senting TMPRSS2-ETV1 transcript.
(F) Sequence analysis of TMPRSS2-ETV1 tran-
scripts in TMPRSS2-ETV1-positive LNCaP cells
obtained by H2O2 stimulation. Gene structures for
TMPRSS2 and ETV1, respectively, are shown
using GenBank: NM_005656 and NM_004956.
See also Figure S7.
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is generated by the injection of sterile air under the dorsal skin of
mice. Injection of an inflammatory irritant (e.g., lipopolysaccha-
rides [LPS]) into the air pouch produces an inflammatory
response that is characterized by the infiltration of inflammatory
cells and the production of cytokines or chemokines (Romano
et al., 1997). We injected 10 million LNCaP cells in control or
LPS-treated air pouches raised in the immunodeficient severe
combined immunodeficiency (SCID) mice or immunocompetent
C57BL/6 mice (Figure 6A). The cells were recovered 24 hr post-
injection by air-pouch lavage. We did not observe TMPRSS2-
ERG gene fusion transcripts in LNCaP cells recovered from the
air pouches of SCID mice with or without LPS treatment. By
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Figure 6. Inflammation Induces In Vivo Gene Fusion Formation
(A) Schematic representation of mouse air-pouch experiments.
(B) TaqMan qRT-PCR assays to determine TMPRSS2-ERG transcript level on cells derived from SCID or C57BL/6 mouse air pouches with indicated treatments
(*p < 0.01 by two-tailed Mann-Whitney U-test) (bottom). Each data point represents the mean of three technical replicates from an independent treatment. Gel-
based RT-PCR analysis with primers spanning the first exon of TMPRSS2 and the sixth exon of ERG for representative samples (top).
(C) FISH analysis to detect TMPRSS2 locus DNA breaks in LNCaP cells derived fromC57BL/6 or SCIDmouse air pouches with indicated treatments. Split signals
representing rearrangements are highlighted by arrows. The FISH images are accompanied by histograms representing the percentage of nuclei with split signals
in TMPRSS2 and ERG. For each treatment, 100 nuclei were analyzed (*p < 0.05 by two-tailed Student’s t test; error bars, SEM of two technical replicates).
(D) F4/80 staining reveals depletion of macrophages in mouse air pouches upon treatment with Clodrosome. Scale bar indicates 5 mm.
(E) Clodrosome treatment resulted in a reduction in total cellular infiltrate in air pouches (*p < 0.01 by two-tailed Student’s t test; error bars, SEM of three mice).
(F) TaqMan qRT-PCR assays determine the TMPRSS2-ERG transcript level in LNCaP cells derived from LPS-stimulated (100 mg) C57BL/6 mouse air pouches
with Encapsome or Clodrosome treatments (*p < 0.01 by two-tailedMann-Whitney U-test). Each data point represents themean of three technical replicates from
an independent treatment.
(G) TaqMan qRT-PCR assays to determine TMPRSS2-ERG transcript level in LNCaP cells derived from LPS-stimulated (100 mg) C57BL/6mouse air poucheswith
vehicle or JQ1 (100 mg/kg) treatments (*p < 0.05 by two-tailed Mann-Whitney U-test). Each data point represents the mean of three technical replicates from an
independent treatment.
See also Figure S7.
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contrast, TMPRSS2-ERG gene fusions were observed in LNCaP
cells injected into the air pouch of C57BL/6 mice, the levels of
which were further accentuated upon treatment with LPS (Fig-
ure 6B). These results suggest that analogous to our in vitro
data, inflammation in vivo induces the formation of TMPRSS2-
ERG gene fusions. We next optimized the split-signal-based
dual-color FISH assay with TMPRSS2 and ERG probes on
LNCaP cells derived from the murine air pouch. These probes
are human specific and do not cross-react with mouse cells (Fig-
ure S7B). Split-signal dual-color FISH assays revealed breaks in
the TMPRSS2 and ERG locus of LNCaP cells derived from
C57BL/6 mice, but not SCID mice (Figures 6C and S7C).
Because LPS was injected in the air pouch 1 day before cell
implantation, a direct effect of LPS on LNCaP cells can be ruled
out. Furthermore, because LPS-treated air pouches in the SCID
mouse background did not induce the formation of gene fusions,
we conclude that the observed effects are a consequence
of host inflammation. In concordance with our previous results
using TNF-a and gamma irradiation, the frequencies of inflam-
mation-induced in vivo breaks were higher at the TMPRSS2
locus compared to the ERG locus. This suggests that DNA
breaks in ERG are a rate-limiting step in the formation of
TMPRSS2-ERG gene fusions. Because the air pouch is a model
of tissue injury, and human LNCaP cells are recognized as a
foreign graft in C57BL/6 mice, there is substantial inflammation
that adversely affects cell viability, given that the cells stay in
the pouch for 24 hr.
Due to the emerging role of macrophages in tumor develop-
ment (Qian and Pollard, 2010), we tested their role in LPS-medi-
ated TMPRSS2-ERG gene fusion formation in the C57BL/6
mouse air-pouch model. We employed a liposome-based
approach to deplete phagocytic cells (macrophages or neutro-
phils) fromC57BL/6mouse air pouches by injecting Clodrosome
(in which clodronate is encapsulated in the aqueous compart-
ment of the liposomes) or Encapsome, the vehicle control (Van
Rooijen and Sanders, 1994; Zeisberger et al., 2006). The lipo-
somes are not taken up by non-phagocytic cells; unencapsu-
lated clodronate cannot cross the cell membrane to initiate cell
death. Macrophage depletion was evaluated by immunofluores-
cence using the F4/80 monoclonal antibody that recognizes a
macrophage-restricted cell surface glycoprotein (Figure 6D).
Macrophage depletion resulted in a reduction in the total cellular
infiltrate in the air pouch, suggesting impaired recruitment of
other immune cells to the air pouch (Figure 6E).
We measured TMPRSS2-ERG gene fusion formation in
LNCaP cells injected into LPS-stimulated C57BL/6 mouse air
pouches with Encapsome treatment and compared this against
treatment with Clodrosome (macrophage-depleted setting).
While the Encapsome-treated group exhibited robust formation
of TMPRSS2-ERG gene fusion, the effect was blocked in the
Clodrosome-treated group (Figure 6F). These data clearly indi-
cate a role for macrophages or neutrophils in TMPRSS2-ERG
gene fusion formation. Because SCID mice contain macro-
phages, we conclude that macrophages are necessary, but
not sufficient, for in vivo gene fusion formation. Our data suggest
that a complex network of interactions between macrophages
and other immune cell types (B and T cells) mediate gene fusion
formation. Reports indicate a role for bromodomain and extrater-
minal domain (BET) protein inhibitors like JQ1 and I-BET in sup-
pressing inflammation (Belkina et al., 2013; Nicodeme et al.,
2010). BET inhibition has been shown to decrease proinflamma-
tory cytokine production in macrophages and ablate inflamma-
tory responses in mouse models. We observe that treatment
with JQ1 blocks TMPRSS2-ERG gene fusion formation in the
air-pouch model for in vivo inflammation (Figure 6G). Because
JQ1 also blocks AR function (Asangani et al., 2014), it is
conceivable that the observed effects are due to a combined
suppression of inflammation and androgen signaling. We
thereby present definitive evidence for the role of inflammation
in gene fusion formation.
DISCUSSION
Altogether, these results implicate a critical role for inflamma-
tion-induced oxidative stress in the formation of DNA breaks
leading to recurrent gene rearrangements in prostate cancer.
Although other potential mechanisms of DNA breaks exist, we
suspect that inflammation-induced oxidative stress may be a
significant contributor of DNA damage. Endonucleases like
RAG and AID have been implicated the formation of DNA breaks,
resulting in genomic rearrangements involving the immunoglob-
ulin loci. For example, the RAG complex and AID are involved
in the formation of the follicular lymphoma-associated t(14;18)
BCL2-IGH translocation and Burkitt’s lymphoma-associated
t(8;14) IGH-MYC translocations, respectively (Ramiro et al.,
2004; Tsujimoto et al., 1985). Because the expression levels of
these endonucleases are very low or undetectable in the normal
prostate or prostate cancers, these are unlikely to be physiolog-
ically relevant in the genesis of prostate cancer-associated
genomic rearrangements. Although transcription can introduce
breaks in 50 gene fusion partners that are highly expressed
(e.g., TMPRSS2), most 30 partners such as ERG and ETV1 exhibit
no or minimal transcription in the prostate gland before gene
fusion formation (Haffner et al., 2010). Thus, transcription alone
cannot explain the formation of DNA breaks in both partner
genes leading to ETS gene fusions. Genotoxic drugs (e.g., clas-
togens), chemotherapeutic drugs (e.g., cisplatin), topoisomer-
ase inhibitors (e.g., camptothecin and etoposide), and other
drugs such as hydroxyurea and aphidicolin can induce DNA
double-strand breaks. ETS gene fusions are early events and
arise in patients before they are treated with any of these drugs.
Thus, exposure to such drugs may not contribute to DNA breaks
leading to ETS gene fusions in prostate cancer. While DNA repli-
cation is considered a major source of DNA breaks, the prostate
luminal cells, which are widely believed to be the cell of origin for
prostate cancer, are post-mitotic cells. Neuroendocrine cells in
the prostate lumen are also post-mitotic. The basal cells of the
prostate have a very low mitotic index. Thus, cell division or
DNA replication is not likely to be a major contributor to DNA
breaks required for ETS gene fusion formation in the prostate.
Although ionizing radiation is an excellent external source of
DNA damage, the in vivo sources of DNA breaks that contribute
to the formation of genomic rearrangements in prostate cancer
are not well defined.
We suggest that inflammation-induced oxidative stress is
a major source of DNA breaks in the human prostate. The
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upstream triggers for inflammation can be diet, lifestyle, infec-
tion, and even the normal process of aging. While the potential
association between inflammation and prostate cancer is not
new, there are few direct mechanistic links of inflammation to
recurrent driver mutations in cancer. By building on earlier
work on chromosomal proximity and DNA rearrangements
(Baca et al., 2013; Berger et al., 2011), our working model sug-
gests that AR induces the proximity of genes such as TMPRSS2
and ERG (Lin et al., 2009; Mani et al., 2009), while inflammatory
stimuli trigger DNA breaks via oxidative stress (Figure 7). Our
studies implicate microhomology-mediated NHEJ as the repair
process contributing to inflammation-induced de novo genomic
rearrangements. The strong association of PIA with human
prostate cancer may represent circumstantial morphologic evi-
dence for this link (De Marzo et al., 1999). These studies sug-
gest that anti-inflammatories may have a role in the chemopre-
vention of prostate cancer, as suggested by published
epidemiological studies (De Marzo et al., 2007; Nelson et al.,
2003; Sfanos and De Marzo, 2012). Broadly, while these studies
have been carried out in a prostate cancer model, the results
suggest a potential role for inflammation-induced oxidative
stress in the genesis of gene fusions across different cancer
types.
EXPERIMENTAL PROCEDURES
Cell Culture, Transfection, Immunofluorescence, and Immunoblot
Analysis
LNCaP and DU145 cells were cultured in RPMI 1640 medium containing 10%
fetal bovine serum (FBS) in a 5%CO2 humidified incubator. LAPC-4 and VCaP
cells were cultured in Iscove’s modified Dulbecco’s medium (IMDM) and
DMEM, respectively, supplemented with 10% FBS.
For in vitro stimulation experiments, cells were treated with 100 ng/mL TNF-
a (Sigma) for various time intervals. For androgen depletion experiments, the
cells were cultured in phenol-red freemedia containing 10%charcoal-stripped
serum (HyClone) for 2 days.
Non-targeting siRNA (D-001810-10), AR siRNA (J-003400-08), ataxia telan-
giectasia mutated (ATM) siRNA (L-003201-00-0050), BRCA1 siRNA (L-
003461-00-0050), and RAD51 siRNA (L-003530-00-0050) were obtained
from Dharmacon. siRNA was transfected using Lipofectamine RNAiMAX
transfection reagent (Invitrogen, #13778-150) according to the manufacturer’s
protocol.
For immunofluorescence analysis, cells were fixed in ice-cold methanol, fol-
lowed by blocking, incubation with primary antibodies against RAD51 (Santa
Cruz Biotechnology, #sc-8349), and detection with anti-rabbit secondary an-
tibodies conjugated to Alexa Fluor 594 (Thermo Fisher Scientific, #A-21207).
Images were captured by confocal microscopy (Zeiss, #LSM 880). The stain-
ing intensity was analyzed using the CellProfiler software (Carpenter et al.,
2006). For immunoblot analysis, mouse monoclonal antibodies against phos-
phorylated histone H2A.X (Ser139) (Millipore, #05-636), rabbit monoclonal an-
tibodies against ERG (Epitomics, #2805-1), and rabbit polyclonal antibodies
against androgen receptor (Millipore, #06-680), histone H2A.X (Cell Signaling
Technology, #2595S), and b-tubulin (Santa Cruz Biotechnology, #sc-9104)
were used.
Gene Expression Studies
qRT-PCR was performed using Power SYBR Green PCR master mix (Applied
Biosystems) or TaqMan Universal PCR master mix (Applied Biosystems) on a
7900HT Fast Real-Time PCR system (Applied Biosystems), as described pre-
viously (Laxman et al., 2006; Mani et al., 2009; Tomlins et al., 2005). To synthe-
size cDNA, 3 mg of total RNA was used. In each RT-PCR analysis, 3% of the
cDNA representing 90 ng of the original RNA was used. Primers for SYBR
green assays forGAPDH and ERG (exons 5 and 6) were as described (Tomlins
et al., 2005). TaqMan gene expression assay for GAPDH was obtained
from Applied Biosystems (Assay ID: Hs00266705_g1). Primers and the
minor groove binder (MGB) probe for TMPRSS2-ERG (TaqMan assay) are
TM_ERGa-3-f: 50-CTGGAGCGCGGCAGGAA-30; TM_ERGa-3-r: 50-CCGTAG
GCACACTCAAACAACGA-30; and TM_ERGa-3-probe: 50-TTATCAGTTGTGA
GTGAGGAC-30. SYBR green GAPDH assay was used for all in vitro studies;
TaqMan GAPDH that is human specific was used for all mouse air-pouch
studies. Primers for TMPRSS2-ERG gel-based nested RT-PCR (Figures 1A
and 6B) are 1For: 50-CAGGAGGCGGAGGCGGA-30; 1Rev: 50-GGCGTTGTAG
CTGGGGGTGAG-30; 2For: 50-AGCGCGGCAGGTTATTCCA-30; and 2Rev:
50-ATCATGTCCTTCAGTAAGCCA-30. The TMPRSS2-ERG TaqMan assay
in LAPC-4 and DU145 cells (Figure 1E) was preceded by 15-cycle pre-
amplification using the 1For and 1Rev primers, as described earlier. qRT-
PCR primers for ATM (#PPH00325C-200), BRCA1 (#PPH00322F-200), and
RAD51 (#PPH00942F-200) were obtained from SABiosciences. Primers for
TMPRSS2-ETV1 gel-based nested RT-PCR (Figure 5E), TMPRSS2-ETV1
qRT-PCR, ACTIN gel-based RT-PCR, and BCR-ABL1 gel-based RT-PCR
and qRT-PCR are described elsewhere (Lin et al., 2009).
ROS Assay
Intracellular ROS was detected by fluorescence-activated cell sorting (FACS)
analysis of60,000 LNCaP cells with various treatments using the Total Reac-
tive Oxygen Species (ROS) Assay Kit 520 nm (eBioscience) according to the
manufacturer’s protocol.
ACCESSION NUMBERS
The accession number for the custom capture sequence data used to detect
genomic breakpoints and reported in this paper (Figures 2D and S3) is NCBI
SRA: SRP090763.
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Proliferative inflammatory atrophy (PIA) is asso-
ciated with inflammatory cells that secrete
pro-inflammatory cytokines (e.g., TNF-a). This
results in the formation of ROS-induced DNA
breaks, which in combination with androgen
signaling-induced proximity between gene fusion
partner loci, can facilitate ETS gene fusion
formation, thereby promoting prostate cancer
development.
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